CVE:ADK

DIAGNOS (ADK) Stock Forecast, Price & News

C$0.54

+0.01 (+0.94%)

(As of 11:57 AM ET)

Compare

Today's Range: C$0.52
▼
C$0.54
50-Day Range: C$0.43
▼
C$0.58
52-Week Range: C$0.15
▼
C$0.59

Volume: 35,500 shs
Average Volume: 116,624 shs
Market Capitalization: C$38.31 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Earnings Insider Trades Headlines

About DIAGNOS (CVE:ADK) Stock

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

ADK Price History

30 days | 90 days | 365 days | Advanced Chart

ADK Stock News Headlines

September 8, 2023 | baystreet.ca

Diagnos, Appulse, Bedford at 52-Week Highs

July 15, 2023 | theglobeandmail.com

Closing Bell: Diagnos Inc down on Friday (ADK)

October 3, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.

July 6, 2023 | markets.businessinsider.com

Echelon Wealth Partners Believes Diagnos (ADK) Won’t Stop Here

May 17, 2023 | finance.yahoo.com

DIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”

May 15, 2023 | baystreet.ca

TMX, Arrow, CPKC at 52-Week Highs on News

May 11, 2023 | usatoday.com

Michael J. Fox: Do you have Parkinson's? New test is 'breakthrough' in diagnosing disease.

May 4, 2023 | theglobeandmail.com

Closing Bell: Diagnos Inc up on Wednesday (ADK)

October 3, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

May 2, 2023 | theglobeandmail.com

Closing Bell: Diagnos Inc up on Monday (ADK)

April 28, 2023 | theglobeandmail.com

Closing Bell: Diagnos Inc up on Thursday (ADK)

April 19, 2023 | theglobeandmail.com

Closing Bell: Diagnos Inc up on Tuesday (ADK)

February 28, 2023 | finance.yahoo.com

DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts

December 15, 2022 | finance.yahoo.com

DIAGNOS Provides Additional Information to the Closing of Private Placement

November 6, 2022 | reuters.com

ADK.V - Diagnos Inc | Stock Price & Latest News | Reuters

October 27, 2022 | finance.yahoo.com

DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology

August 18, 2022 | finance.yahoo.com

DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems

July 27, 2022 | finance.yahoo.com

DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics

June 7, 2022 | finance.yahoo.com

DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group

May 26, 2022 | stockhouse.com

DIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening

May 12, 2022 | yahoo.com

Ex-attorney general Eric Holder on gerrymandering: 'Republicans have to cheat' in elections

February 10, 2022 | finance.yahoo.com

DIAGNOS Successfully Completes ISO / MDSAP Audit

October 28, 2021 | nz.finance.yahoo.com

DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA

August 17, 2021 | ca.finance.yahoo.com

DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders

August 16, 2021 | stockhouse.com

DIAGNOS signs Memorandum of Understanding with Essilor International.

July 20, 2021 | finance.yahoo.com

DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE

March 4, 2021 | finance.yahoo.com

DIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technology

See More Headlines

Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Company Calendar

Last Earnings: 8/24/2023
Today: 10/03/2023
Next Earnings (Estimated): 12/05/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Health Information Services
Sub-Industry: N/A
Sector: Medical
Current Symbol: CVE:ADK
CUSIP: N/A
CIK: N/A
Web: www.diagnos.ca
Phone: +1-450-6788882
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-2,520,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -126.68%

Debt

Debt-to-Equity Ratio: 245.28
Current Ratio: 1.38
Quick Ratio: 0.68

Sales & Book Value

Annual Sales: C$577,486.00
Price / Sales: 65.72
Cash Flow: C$0.01 per share
Price / Cash Flow: 60.00
Book Value: C($0.03) per share
Price / Book: -17.67

Miscellaneous

Outstanding Shares: 71,610,000
Free Float: N/A
Market Cap: C$37.95 million
Optionable: Not Optionable
Beta: -0.07

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Andre Larente
CEO, Pres & Exec. Director

Mr. Marc-André Massue
VP of Fin., CFO & Sec.

Mr. Martin Beland
Director of Marketing

Key Competitors

View All Competitors

Insiders

Marc-André Massue
Sold 1,000 shares
Total: C$270.00 ($0.27/share)

View All Insider Transactions

ADK Stock - Frequently Asked Questions

How have ADK shares performed in 2023?: DIAGNOS's stock was trading at C$0.28 at the beginning of the year. Since then, ADK stock has increased by 89.3% and is now trading at C$0.53.
View the best growth stocks for 2023 here.
When is DIAGNOS's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 5th 2023.
View our ADK earnings forecast.
How were DIAGNOS's earnings last quarter?: DIAGNOS Inc. (CVE:ADK) posted its earnings results on Thursday, August, 24th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company earned $0.04 million during the quarter, compared to analysts' expectations of $0.10 million.
What other stocks do shareholders of DIAGNOS own?: Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).

What is DIAGNOS's stock symbol?: DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."
How do I buy shares of DIAGNOS?: Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is DIAGNOS's stock price today?: One share of ADK stock can currently be purchased for approximately C$0.53.
How much money does DIAGNOS make?: DIAGNOS (CVE:ADK) has a market capitalization of C$37.95 million and generates C$577,486.00 in revenue each year. The company earns C$-2,520,000.00 in net income (profit) each year or C($0.04) on an earnings per share basis.
How can I contact DIAGNOS?: DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The official website for the company is www.diagnos.ca. The company can be reached via phone at +1-450-6788882.

This page (CVE:ADK) was last updated on 10/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial